Evidence map›Paper›PMID 37120568›Full record

ReviewOrphanet journal of rare diseases2023

Esophageal papillomatosis: an exceedingly rare disease.

Dandan Li, Changfeng Li, Yuxing Yan, Minya Liu

Abstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dandan LiDepartment of Gastrointestinal Medicine (Endoscopy Center), Jilin University, China-Japan Union Hospital, 126 Xiantai Street, Erdao, Changchun, 130033, People's Republic of China. lidd@jlu.edu.cn.ORCID 0000-0002-9241-0642
Changfeng LiDepartment of Gastrointestinal Medicine (Endoscopy Center), Jilin University, China-Japan Union Hospital, 126 Xiantai Street, Erdao, Changchun, 130033, People's Republic of China.
Yuxing YanDepartment of Gastrointestinal Medicine (Endoscopy Center), Jilin University, China-Japan Union Hospital, 126 Xiantai Street, Erdao, Changchun, 130033, People's Republic of China.
Minya LiuDepartment of Gastrointestinal Medicine (Endoscopy Center), Jilin University, China-Japan Union Hospital, 126 Xiantai Street, Erdao, Changchun, 130033, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

If esophageal papilloma (EP) is a rare condition, esophageal papillomatosis (EPS) is a distinct rarity. To date, only 53 well documented cases have been described in English literature. However, the number of reports on EPS significantly increased to over 40 cases during the past 20 years. Perhaps, this is due to the broad use of endoscopy and related research achievements. Most of the cases are individual and it seems that there are no associations between them. And up to now no guidelines can be followed. To further understand this exceedingly rare disease, we had a comprehensive review of the epidemiology, etiology, clinical manifestations, pathogenesis, treatment, and clinical course of EPS.

Indexed as

Esophageal NeoplasmsPapillomaEndoscopyHumansRare DiseasesEndoscopyEsophageal cancerEsophageal papillomatosisHuman papilloma virusTreatment

Identifiers

PMID37120568
PMCPMC10149006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.